Literature DB >> 4636293

14 C-glucose oxidation in whole blood: a clinical assay for phagocyte dysfunction.

G T Keusch, S D Douglas, D Mildvan, S Z Hirschman.   

Abstract

A screening test for chronic granulomatous disease is described; it is based on abnormal oxidation of glucose-1-(14)C to (14)CO(2) during phagocytosis by leukocytes in whole blood.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4636293      PMCID： PMC422384          DOI： 10.1128/iai.5.3.414-415.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  Acid phosphatase cytochemistry of phagocytizing leukocytes from patients with chronic granulomatous disease.

Authors:  S D Douglas; S S Spicer
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

2.  Quantitative nitroblue tetrazolium test in chronic granulomatous disease.

Authors:  R L Baehner; D G Nathan
Journal:  N Engl J Med       Date:  1968-05-02       Impact factor: 91.245

3.  A simple rapid micromethod for detecting chronic granulomatous disease of childhood.

Authors:  R H Gifford; S E Malawista
Journal:  J Lab Clin Med       Date:  1970-03

4.  Granulocytopathies: pleomorphism of neutrophil dysfunction.

Authors:  S D Douglas; W C Davis; H H Fudenberg
Journal:  Am J Med       Date:  1969-06       Impact factor: 4.965

Review 5.  Analytic review: disorders of phagocyte function.

Authors:  S D Douglas
Journal:  Blood       Date:  1970-06       Impact factor: 22.113

6.  Biochemical effects of cholera enterotoxin. II. Glucose metabolism in the intestine of the infant rabbit.

Authors:  G T Keusch; L Weinstein; G F Grady
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

7.  Fatal (chronic) granulomatous disease of childhood: a hereditary defect of leukocyte function.

Authors:  R A Good; P G Quie; D B Windhorst; A R Page; G E Rodey; J White; J J Wolfson; B H Holmes
Journal:  Semin Hematol       Date:  1968-07       Impact factor: 3.851

8.  Hexose monophosphate shunt activity of circulating phagocytes in acute lymphocytic leukemia.

Authors:  R T Skeel; R A Yankee; E S Henderson
Journal:  J Lab Clin Med       Date:  1971-06

9.  Leukocyte preservation. I. Phagocytic stimulation of the hexose monophosphate shunt as a measure of cell viability.

Authors:  R T Skeel; R A Yankee; W A Spivak; L Novikovs; E S Henderson
Journal:  J Lab Clin Med       Date:  1969-02

10.  Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function.

Authors:  B Holmes; A R Page; R A Good
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808
View more
  6 in total

1.  A defect in neutrophil motility in two siblings with recurrent infections and a remarkable family history.

Authors:  F T Sacchi; F A Ferrari; A Fortunato; G Maggiore; M Marconi; A Pagani; A G Siccardi
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.

Authors:  L I Gordon; S D Douglas; N E Kay; O Yamada; E F Osserman; H S Jacob
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

3.  Neutrophil function in lymphoreticular malignancy.

Authors:  B W Hancock; L Bruce; J Richmond
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

4.  Defective phagocyte Aspergillus killing associated with recurrent pulmonary Aspergillus infections.

Authors:  A Fietta; F Sacchi; P Mangiarotti; G Manara; G Gialdroni Grassi
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

5.  Defective Aspergillus killing by neutrophil leucocytes in a case of systemic aspergillosis.

Authors:  A Pagani; R Spalla; F A Ferrari; M Duse; L Lenzi; U Bretz; M Baggiolini; A G Siccardi
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.

Authors:  C B Wilson; V Tsai; J S Remington
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.